Green Chemistry Market Key Highlights and Future Opportunities Till 2035 Green chemistry focuses on designing chemical products and processes that reduce or eliminate the use and generation of hazardous substances. In the pharmaceutical industry, companies are increasingly adopting biocatalysis, solvent reduction, and waste-minimization strategies to improve efficiency, lower costs, and meet sustainability targets. Over 65 documented use-cases already demonstrate measurable benefits such as higher yields, shorter manufacturing times, and reduced solvent consumption. Central to these efforts is the Green Chemistry Market, which continues to evolve as regulatory pressure and corporate sustainability commitments intensify. Leading pharmaceutical companies including Amgen, AstraZeneca, Bristol Myers Squibb, Merck, Pfizer, and Johnson & Johnson have implemented green chemistry initiatives across research and manufacturing. Solution providers such as Codexis and Merck KGaA support the transition with specialized technologies and services. Key drivers include stricter environmental regulations, demand for lower-carbon manufacturing, and the economic advantages of more efficient processes. While the broader green chemistry opportunity spans multiple industries, pharmaceutical applications remain a significant and growing focus. As more companies integrate green chemistry principles into their operations, the market is expected to expand steadily through the coming decade. Read More: https://www.rootsanalysis.com/reports/green-chemistry-market.html